Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study.

Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study. Abstract Text:

Niraj Varma,

Increased implantable cardioverter defibrillator (ICD) implant volumes (and product advisories/recalls) pose management challenges. Most device interrogations at 3- to 6-month routine follow-up visits are "nonactionable," that is, require no clinically significant reprogramming, lead revision, or initiation or up-titration of antiarrhythmic medications. Conversely, implanted devices collect important diagnostic data (eg, atrial fibrillation onset, system integrity) that remain concealed between device interrogations. Remote monitoring may resolve some of these challenges, but has not been studied in a large-scale clinical trial. Home Monitoring (HM) uses automatic (without patient intervention) data and electrogram transmissions with rapid (<24 hours) event notification of significant (including silent) events. The Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) is a multicenter, prospective, randomized study enrolling 1000 ICD patients designed to test whether HM can safely reduce the number of scheduled nonactionable office device interrogations by 50% and provide early detection and notification of cardiac and/or device problems. After enrollment, TRUST patients are randomized 2:1 to either HM or to control (ie, HM off) arms and are seen for an in-office follow-up 3 months postimplant. At subsequent 3-month intervals, control patients have conventional office visits, whereas in HM, patient data are remotely retrieved and evaluated. In HM patients, early notification may automatically occur between periodic checks for compromised system integrity (battery, lead parameters, high-voltage circuitry) or arrhythmia occurrence (eg, atrial fibrillation, ventricular arrhythmia). All study patients will have a final office visit 15 months after implant. The results of TRUST may confirm the role of remote monitoring as an intensive surveillance mechanism for device management.

Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study. Publishing Authors By Initials

N Varma,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study. Journal Published:

PUBLICATION TYPE: Randomized Controlled Trial

Journal: American heart journal

VOLUME: 154

Page Numbers: 1029-34

Journal Abbreviation: Am. Heart J.

ISSN: 1097-6744

DAY: 27

MONTH: 09

YEAR: 2007

Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370465

Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study.

AFFILIATION: Cardiac Electrophysiology Laboratory, Loyola University Medical Center, Maywood, IL 60153, USA. nivarma@lumc.edu

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Am Heart J

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study TRUST study Related Publications

• A case of acute coronary thrombosis in diffuse coronary artery ectasia.
• A case of do-it-yourself Mohs' surgery using bloodroot obtained from the internet.
• A growth and division model for retinoblastoma.
• Anticoagulation plus aspirin following acute myocardial infarction: yes or no ... and if the latter, why not?
• Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand.
• Cardiovascular Risk Factors and Age-related Macular Degeneration: The Los Angeles Latino Eye Study.
• Comments on "neurological soft signs in schizophrenic patients treated with conventional and atypical antipsychotics".
• Distinguishing between acute and serous otitis media.
• Effects of corneal thickness, corneal curvature, and intraocular pressure level on Goldmann applanation tonometry and dynamic contour tonometry.
• External proficiency testing programme & quality of haematology tests in India.
• Giant mediastinal cystic hygroma in a child.
• Greener and sustainable approaches to the synthesis of pharmaceutically active heterocycles.
• INHIBITION OF SYMPATHOMIMETIC EFFECTS ON THE HEART.
• Induction of ultraviolet cataracts in vitro: prevention by pyruvate.
• Josephson effect for superconductors lacking time-reversal and inversion symmetries.
• Lingual thyroid.
• Metal complexes of crosslinked chitosans Part II. An investigation of their hydrolysis to chitooligosaccharides using chitosanase.
• Polyarteritis nodosa in hairy cell leukaemia: an autopsy report.
• Prevalence of obesity and associated co-morbid conditions in a population-based sample of primarily urban Mexican Americans.
• Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study.
• Retinopathy in persons without diabetes: the Los Angeles Latino Eye Study.
• Rubinstein Taybi syndrome.
• Scabies and its treatment.
• Stereotactic neurosurgery for disabling tremor in multiple sclerosis: thalamotomy or deep brain stimulation?
• Synthesis of thermally stable carboxymethyl cellulose/metal biodegradable nanocomposites for potential biological applications.
• The organization of thinking: what functional brain imaging reveals about the neuroarchitecture of complex cognition.
• Theory of the quantum critical fluctuations in cuprate superconductors.
• Visual acuity testability in African-American and Hispanic children: the multi-ethnic pediatric eye disease study.
• Vulgarism of meat eating.
• What angle-resolved photoemission experiments tell about the microscopic theory for high-temperature superconductors.